Uterine artery embolization (UAE) is a minimally invasive option for females with symptomatic leiomyomas. Studies detailing a possible risk with an intrauterine device (IUD) in situ during UAE are limited. A 43-year-old female (Gravida 2, Para 2) underwent UAE with an IUD in situ. On post-procedure day 2, the patient presented with severe lower abdominal pain and mild leukocytosis. Following removal of her IUD, the patient experienced immediate pain relief. Caution is given to clinicians who wish to perform UAE with an IUD in situ.
© 2020 The Authors. Published by the British Institute of Radiology.